enVVeno Medical (NVNO) Market Capitalization (2018 - 2026)

enVVeno Medical has reported Market Capitalization for 9 years, with the latest figure at $7.2 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 90.61% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $7.2 million, a 90.61% decrease from a year earlier, with the FY2025 full-year figure at $7.4 million, down 86.09% from the prior year.
• Market Capitalization was $7.2 million for Q2 2026 at enVVeno Medical, up from $6.6 million in the prior quarter.
• The five-year high for Market Capitalization was $76.8 million in Q2 2025, with the low at $6.6 million in Q1 2026.
• Average Market Capitalization over 5 years is $45.2 million, with a median of $49.7 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Market Capitalization soared 139.88% in 2024, then sank 90.61% in 2026.
• Over 5 years, Market Capitalization stood at $48.3 million in 2022, then soared by 41.7% to $68.4 million in 2023, then declined by 22.63% to $53.0 million in 2024, then sank by 86.09% to $7.4 million in 2025, then decreased by 2.14% to $7.2 million in 2026.
• The last three Market Capitalization figures came in at $7.2 million (Q2 2026), $6.6 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.